Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dejager

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 22, 2007
Vildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose studyS Dejager, S Razac, J E Foley, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1992
Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblastsR E Pitas, A Friera, J McGuire, et al.
Diabetes & Metabolism|September 22, 2012
Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS studyA Penfornis, I Bourdel-Marchasson, S Quere, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 19, 2007
Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with Type 2 diabetesA Schweizer, A Couturier, J E Foley, et al.
Reviews in Endocrine & Metabolic Disorders|January 25, 2016
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapyL Monnier, C Colette, S Dejager, et al.
Presse Medicale (Paris, France : 1983)|April 15, 1995
[Acute hyponatremia after resection of a pituitary micro-adenoma by transphenoidal approach]G Turpin, L Foubert, C Pichard, et al.
Presse Medicale (Paris, France : 1983)|January 18, 1997
[Adrenal incidentalomas disclosing enzyme block in a 66-year-old man]G Turpin, V Jullien, S Dejager, et al.
The Journal of Clinical Investigation|August 1, 1993
Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variantsS Dejager, M Mietus-Snyder, A Friera, et al.
Thrombosis Research|December 10, 1999
Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold valueR Chadarevian, E Bruckert, S Dejager, et al.
International Journal of Clinical Practice|September 1, 2006
Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French SurveyM Farnier, P Garnier, C Yau, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 22, 2007
Vildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose studyS Dejager, S Razac, J E Foley, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1992
Further characterization of the acetyl LDL (scavenger) receptor expressed by rabbit smooth muscle cells and fibroblastsR E Pitas, A Friera, J McGuire, et al.
Diabetes & Metabolism|September 22, 2012
Real-life comparison of DPP4-inhibitors with conventional oral antidiabetics as add-on therapy to metformin in elderly patients with type 2 diabetes: the HYPOCRAS studyA Penfornis, I Bourdel-Marchasson, S Quere, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 19, 2007
Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with Type 2 diabetesA Schweizer, A Couturier, J E Foley, et al.
Reviews in Endocrine & Metabolic Disorders|January 25, 2016
Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapyL Monnier, C Colette, S Dejager, et al.
Presse Medicale (Paris, France : 1983)|April 15, 1995
[Acute hyponatremia after resection of a pituitary micro-adenoma by transphenoidal approach]G Turpin, L Foubert, C Pichard, et al.
Presse Medicale (Paris, France : 1983)|January 18, 1997
[Adrenal incidentalomas disclosing enzyme block in a 66-year-old man]G Turpin, V Jullien, S Dejager, et al.
The Journal of Clinical Investigation|August 1, 1993
Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variantsS Dejager, M Mietus-Snyder, A Friera, et al.
Thrombosis Research|December 10, 1999
Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold valueR Chadarevian, E Bruckert, S Dejager, et al.
International Journal of Clinical Practice|September 1, 2006
Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French SurveyM Farnier, P Garnier, C Yau, et al.
Pageof 5